Hypogeusia and hyposmia with topical 5-fluorouracil treatment

Hypogeusia and hyposmia with topical 5-fluorouracil treatment

Bibliographic Details
Main Authors:	Auston Gillis, BS, Lindsay Eminger, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	JAAD Case Reports
Subjects:	dihydropyrimidine dehydrogenase hypogeusia hyposmia topical fluorouracil
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620303039

Similar Items

Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
by: Ide Hiroki, et al.
Published: (2012-09-01)

Neurosensory dysfunction: A diagnostic marker of early COVID-19
by: Yujie Liang, et al.
Published: (2020-09-01)

High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity
by: Emma eBorràs, et al.
Published: (2013-01-01)

Monitoring of the 5-FU therapy: Safety and efficacy of treatment?
by: Angelika Szczęśniak, et al.
Published: (2018-03-01)

Dihydropyrimidine dehydrogenase deficiency as a cause of fatal 5-Fluorouracil toxicity
by: Shiraz S. Fidai, et al.
Published: (2018-12-01)

Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression
by: Kikuchi, Osamu
Published: (2016)

Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients
by: Reza Negarandeh, et al.
Published: (2020-06-01)

Hyposmia in geriatric depression can be a meningioma
by: Muruganandam Partheeban, et al.
Published: (2019-01-01)

<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
by: Theodore J. Wigle, et al.
Published: (2019-05-01)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
by: Mao CJ, et al.
Published: (2017-10-01)

Unawareness of hyposmia in patients with idiopathic Parkinson’s disease
by: Utkarsh Patel, et al.
Published: (2020-01-01)

DPD status and fluoropyrimidines-based treatment: high activity matters too
by: Emmanuel Chamorey, et al.
Published: (2020-05-01)

Investigation of Ivs14+1G>A Polymorphism of Dpyd Gene in a Group of Bosnian Patients Treated with 5-Fluorouracil and Capecitabine
by: Timur Cerić, et al.
Published: (2010-05-01)

Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
by: Vijay M Patil, et al.
Published: (2016-01-01)

Comparison between four published definitions of hyposmia in Parkinson's disease
by: Sofia Kanavou, et al.
Published: (2021-08-01)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
by: Yuanyuan Li, et al.
Published: (2017-09-01)

Effects of Combined Intralesional 5-Fluorouracil and Topical Silicone in Prevention of Keloids: A Double Blind Randomized Clinical Trial Study
by: Hamid Reza Ghafarian Shirazi, et al.
Published: (2011-03-01)

Effects of Combined Intralesional 5-Fluorouracil and Topical Silicone in Prevention of Keloids: A Double Blind Randomized Clinical Trial Study
by: Ebrahim Hatamipour, et al.
Published: (2011-03-01)

TASTE SENSITIVITY VARIATIONS IN DIFFERENT SYSTEMIC DISEASES
by: Jipu Raluca, et al.
Published: (2020-07-01)

Assessment of the difference in detection of pleasant and unpleasant odors in different grades of hyposmia
by: Tamer M. Attia, et al.
Published: (2021-02-01)

An Evaluation of the Diagnostic Accuracy of a Panel of Variants in <i>DPYD</i> and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities
by: Claire Palles, et al.
Published: (2021-03-01)

Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota
by: Chao Li, et al.
Published: (2021-04-01)

Modeling of 5-fluorouracil infulence on activity of its’ metabolic enzymes
by: M. Stashkevych
Published: (2015-11-01)

Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving Fluorouracil
by: Lauren E. Winquist, et al.
Published: (2021-12-01)

α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson’s disease model
by: Taguchi, Tomoyuki
Published: (2021)

Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil
by: Jung Ho Han, et al.
Published: (2021-05-01)

Anosmia/Hyposmia is a Good Predictor of Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis
by: Timotius Ivan Hariyanto, et al.
Published: (2021-01-01)

Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial
by: Mitsuru Ishizuka, et al.
Published: (2016-07-01)

Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
by: Tanaka, Daisuke, et al.
Published: (2005)

Intraoperative infiltration against topical application of 5-fluorouracil in pterygium treatment
by: Basem M Ibrahim, et al.
Published: (2017-01-01)

Treatment of porokeratosis of Mibelli with combined use of topical fluorouracil and calcipotriene
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2021-03-01)

Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions
by: Akira Kanda, et al.
Published: (2019-02-01)

Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature
by: Nedal Bukhari, et al.
Published: (2021-07-01)

Comparative efficacy of topical 5% 5-fluorouracil with electrosurgery in treatment of warts
by: Dogra Alka, et al.
Published: (2006-01-01)

Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity
by: Saif MW
Published: (2020-10-01)

In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
by: Eiji Hishinuma, et al.
Published: (2020-07-01)

Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine
by: Mahshid Mohammadian, et al.
Published: (2019-08-01)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
by: Raffaele Palmirotta, et al.
Published: (2019-03-01)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
by: Felicia Stefania Falvella, et al.
Published: (2015-04-01)

Dihydropyrimidine dehydrogenase level and the redox status in patients with colorectal cancer are prognostic for adverse effects of fluoropyrimidines
by: Nadya G. Hristova-Avakumova, et al.
Published: (2021-01-01)